GlassScriptPhysician profile
Amanda Michele Meyer
NPI 1811655004
$654.78
in general payments reported to CMS, 2019-2025
14 companies · $474 in 2025
The $474 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.19 · 2023: $34.47 · 2024: $135 · 2025: $474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $643.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $191.24 | 2025 | Carto 3, Nuvision Ice Catheter |
| Abbvie INC. | $130.66 | 2024-2025 | |
| Glaxosmithkline, LLC. | $88.10 | 2025 | Trelegy Ellipta |
| Shield Therapeutics INC | $39.99 | 2024 | |
| Exact Sciences Corporation | $35.47 | 2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $35.27 | 2023-2025 | Mounjaro, Zepbound |
| Merz North America, INC. | $23.95 | 2024 | |
| Axsome Therapeutics, INC. | $20.81 | 2025 | Auvelity |
| Viatris Specialty LLC | $17.69 | 2025 | Yupelri |
| Dexcom, INC. | $15.76 | 2023 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $15.24 | 2025 | |
| Pfizer INC. | $15.03 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $14.38 | 2024 | Airsupra |
| W. L. Gore & Associates, INC. | $11.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.